Evidence map›Paper›PMID 11158610›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Activated Cdc42/Rac reconstitutes Fcepsilon RI-mediated Ca2+ mobilization and degranulation in mutant RBL mast cells.

E Hong-Geller, D Holowka, R P Siraganian, B Baird, R A Cerione

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Mast cells. Receptors, secretagogues, and signaling.Clinical reviews in allergy & immunology · 2002
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

E Hong-GellerDepartments of Molecular Medicine, and Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
D Holowka
R P Siraganian
B Baird
R A Cerione
National Institutes of Health · USNational Institute of Dental and Craniofacial Research · US

Funding

Roles of Cdc42 and its signaling partners in cell growth and differentiationR01GM047458 · NIGMS · CORNELL UNIVERSITY ITHACA · PI CERIONE, RICHARD A. · 1992 to 2016
$5.6M
Signal Transduction In Mast CellsZ01DE000696 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI SIRAGANIAN, REUBEN P. · 1999 to 2008
$3.8M
INTERACTIVE STRUCTURES AND DYNAMICS OF ANTIGEN RECEPTORSR01AI022449 · NIAID · CORNELL UNIVERSITY ITHACA · PI HOLOWKA, DAVID A · 1985 to 2014
$3.6M
NIAID NIH HHS AI22449NIAID NIH HHS R01 AI022449NIGMS NIH HHS GM47458NIGMS NIH HHS R01 GM047458
6 · The paper itself

Abstract

Antigen stimulation of mast cells via FcepsilonRI, the high-affinity receptor for IgE, triggers a signaling cascade that requires Ca(2+) mobilization for exocytosis of secretory granules during an allergic response. This study investigates critical signaling components by using mutant RBL mast cells that are defective in antigen-stimulated phospholipase Cgamma (PLCgamma) activation, as well as other signaling activities downstream of stimulated tyrosine phosphorylation. We show that the expression of activated versions of the Cdc42 or Rac1 GTPase restores antigen-stimulated Ca(2+) mobilization necessary for degranulation in these mutant cells. Wild-type Cdc42 and Rac1, as well as activated Cdc42 containing effector domain mutations, all fail to restore antigen-stimulated signaling leading to exocytosis. Expression of oncogenic Dbl, a guanine nucleotide exchange factor for Cdc42 and Rac1, partially restores sustained Ca(2+) mobilization and degranulation, suggesting that activation of endogenous Cdc42 and/or Rac1 is impaired in the mutant cells. Overexpression of PLCgamma1 with either activated Cdc42 or Rac1 synergistically stimulates degranulation, consistent with a critical defect in PLCgamma activation in these cells. Thus, our results point to activation of Cdc42 and/or Rac1 playing an essential role in antigen stimulation of early events that culminate in mast cell degranulation.

Indexed as

AnimalsCalciumCalcium Signalingcdc42 GTP-Binding ProteinCell DegranulationCell LineEnzyme ActivationIsoenzymesMast CellsPhospholipase C gammarac GTP-Binding ProteinsRatsReceptors, IgERecombinant ProteinsTransfectionType C PhospholipasesCalciumcdc42 GTP-Binding ProteinIsoenzymesPhospholipase C gammarac GTP-Binding ProteinsReceptors, IgERecombinant ProteinsType C Phospholipases

Identifiers

PMID11158610
PMCPMC14724
OpenAlexW2170691881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.